- Home
- TOVX vs SDSTW Comparison
TOVX vs SDSTW Comparison
Compare TOVX & SDSTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOVX
- SDSTW
- Stock Information
- Founded
- TOVX 2001
- SDSTW N/A
- Country
- TOVX United States
- SDSTW United States
- Employees
- TOVX N/A
- SDSTW 8
- Industry
- TOVX Biotechnology: Pharmaceutical Preparations
- SDSTW
- Sector
- TOVX Health Care
- SDSTW
- Exchange
- TOVX Nasdaq
- SDSTW Nasdaq
- Market Cap
- TOVX 4.5M
- SDSTW 3.8M
- IPO Year
- TOVX 2006
- SDSTW N/A
- Fundamental
- Price
- TOVX $0.41
- SDSTW $0.12
- Analyst Decision
- TOVX Hold
- SDSTW
- Analyst Count
- TOVX 1
- SDSTW 0
- Target Price
- TOVX N/A
- SDSTW N/A
- AVG Volume (30 Days)
- TOVX 1.0M
- SDSTW 41.6K
- Earning Date
- TOVX 11-11-2025
- SDSTW 03-26-2025
- Dividend Yield
- TOVX N/A
- SDSTW N/A
- EPS Growth
- TOVX N/A
- SDSTW N/A
- EPS
- TOVX N/A
- SDSTW N/A
- Revenue
- TOVX N/A
- SDSTW N/A
- Revenue This Year
- TOVX N/A
- SDSTW N/A
- Revenue Next Year
- TOVX N/A
- SDSTW N/A
- P/E Ratio
- TOVX N/A
- SDSTW N/A
- Revenue Growth
- TOVX N/A
- SDSTW N/A
- 52 Week Low
- TOVX $0.37
- SDSTW $0.10
- 52 Week High
- TOVX $4.29
- SDSTW $0.12
- Technical
- Relative Strength Index (RSI)
- TOVX 46.90
- SDSTW N/A
- Support Level
- TOVX $0.38
- SDSTW N/A
- Resistance Level
- TOVX $0.45
- SDSTW N/A
- Average True Range (ATR)
- TOVX 0.02
- SDSTW 0.00
- MACD
- TOVX 0.00
- SDSTW 0.00
- Stochastic Oscillator
- TOVX 46.71
- SDSTW 0.00
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.
About SDSTW Stardust Power Inc. Warrant
Stardust Power Inc is developing a lithium refinery at its Facility in Muskogee, Oklahoma, with planned capacity of producing up to 50,000 metric tons per annum of BGLC once fully operational. The company will source lithium brine feedstock from various suppliers and may make investments upstream to secure additional feedstock. The Company seeks to sell its products to electric vehicle (EV) manufacturers as the primary market, with potential applications in other areas such as battery manufacturers, the U.S. military, and original equipment manufacturers (OEMs).